Rheumatology/Arthritis Market Research Reports & Industry Analysis
Some evidence suggests that excessive immune responses may be due to glucocorticoid resistance in target tissues. For example, the number of glucocorticoid receptors in circulating leukocytes is decreased 50% in patients with RA. This decrease in receptors would prevent adequate suppression of leukocyte activity and could further enhance inflammation.Rheumatologists remain the most up-to-date health professionals in autoimmune disease treatment. Early intervention has been noted by nearly all in the field as the single most important factor in treatments and continued quality of life. New advancements in risk factors, diagnosis, and therapies have made it possible for rheumatologist to treat these conditions successfully with the best possible outcomes.
Successful treatment of autoimmune diseases have resulted from a growing array of therapies available to specialists. Symptomatic treatments have traditionally been used for patients with rheumatoid arthritis, lupus and other autoimmune disorders. While these treatments are still used regularly, new disease-modifying therapies have produced the most impressive results in treating these diseases. Additionally, combination therapies continue to grow in preference and offer exciting results in disease management.
Rheumatology/Arthritis Industry Research & Market Reports
-
The 2025-2030 World Outlook for Anti-Arthritic Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Rheumatoid Arthritis Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Small Molecule Therapies for Rheumatoid Arthritis
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Rheumatoid Arthritis Pharmaceutical Therapeutics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Rheumatology Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Drugs for Rheumatoid Arthritis
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Rheumatoid Arthritis Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Rheumatoid Arthritis Autoinjectors
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Rheumatoid Arthritis Diagnosis Tests
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Rheumatoid Arthritis Diagnostic Serology Tests
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Musculoskeletal Diseases
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
2024 Global Forecast for Low-Code Development Platform Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Computer Systems Design Services industry. The product or service category is within the NAICS Computer Systems Design Services industry. The global market is expected to ... Read More
-
US Generic Drug Market Report by Segment (Unbranded, Branded), Therapy Area (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) 2024-2032
... US generic drug market size reached US$ 90.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 124.3 Billion by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032. The ... Read More
-
Rheumatology Therapeutics Market by Indication (Ankylosing Spondylitis, Gout, Osteoarthritis), Distribution Channel (Offline Mode, Online Stores) - Global Forecast 2024-2030
... reach USD 33.24 billion in 2024, at a CAGR 6.51% to reach USD 48.58 billion by 2030. Global Rheumatology Therapeutics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Rheumatology Therapeutics ... Read More
-
Generic Musculoskeletal Disorders Drugs Global Market Report 2024
... By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Drug Store; Online PharmacyCovering: Pfizer Inc.; Sanofi S.A.; Eli Lilly and Company; Ampio Pharmaceuticals Inc.; Amgen Inc. Generic Musculoskeletal Disorders Drugs Global Market Report 2024 from The Business ... Read More
-
Tofacitinib Global Market Opportunities And Strategies To 2032 Including: 1) By Drug Class: Antirheumatic; Janus kinase inhibitor; Immunosuppressant 2) By Dosage Strength: 5mg; 10mg; 11mg; 22mg 3) By Indication: Ulcerative Colitis; Rheumatoid Arthritis; Psoriasis 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy Covering: Pfizer Inc.; Beacon Pharmaceuticals PLC; Pharmascience Inc.; Qilu Pharmaceutical Co., Ltd; Delta Pharma Limited
... Pharmacy; Retail Pharmacy; Online PharmacyCovering: Pfizer Inc.; Beacon Pharmaceuticals PLC; Pharmascience Inc.; Qilu Pharmaceutical Co., Ltd; Delta Pharma Limited Tofacitinib Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; ... Read More
-
Rheumatoid Arthritis (RA) - Competitive Landscape
... 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for RA. There are 19 leading marketed drugs for the treatment of RA. There are 13 drugs in pre-registration stage, including innovator products and biosimilars. ... Read More
-
Autoimmune Disease Diagnostics: Global Markets
... and region. Report Includes: 41 data tables and 30 additional tables An overview of the global market landscape related to the autoimmune disease diagnostics In-depth analysis of global market trends, featuring historical revenue data for ... Read More
-
Global Rheumatoid Arthritis Drugs Market 2024-2028
... rheumatoid arthritis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Orthopedic Regenerative Medicine Market, By Type (Stem Cell, Biomaterial and Tissue Engineering), By Application (Osteoarticular Diseases, Rheumatoid Arthritis, Ligament Injuries, Burisitis, Osteoporosis and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
... and Africa) Orthopedic Regenerative Medicine Market, By Type (Stem Cell, Biomaterial and Tissue Engineering), By Application (Osteoarticular Diseases, Rheumatoid Arthritis, Ligament Injuries, Burisitis, Osteoporosis and Others), By Region (North America, Latin America, Europe, Asia Pacific, ... Read More
-
United States Regenerative Medicine Market By Type (Cell Therapies, Gene Therapies, Progenitor & Stem Cell Therapies, Tissue Engineered Products), By Material (Biologically Derived Material, Synthetic Material, Pharmaceuticals, Genetically Engineered Material), By Application (Musculoskeletal Disorders, Wound Care, Oncology, Ophthalmology, Neurology, Dermatology, Others), By Region, Competition, Forecast and& Opportunities, 2018-2028F
... Care, Oncology, Ophthalmology, Neurology, Dermatology, Others), By Region, Competition, Forecast and& Opportunities, 2018-2028F United States Regenerative Medicine Market is anticipated to project steady growth in the forecast period. Regenerative Medicine is an incredibly fascinating and ... Read More
-
United States Autoimmune Disease Diagnostics Market By Component (Instruments, Reagents, Consumables), By Test Type (Routine Laboratory Tests, Inflammatory Markers, Antibodies & Immunologic Tests, Others), By Disease Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics) By Systemic Autoimmune Diseases (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus, Others), By Localized Autoimmune Diseases (Multiple Sclerosis, Type 1 Diabetes, Hashimoto’s Thyroiditis, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F
... By Systemic Autoimmune Diseases (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus, Others), By Localized Autoimmune Diseases (Multiple Sclerosis, Type 1 Diabetes, Hashimoto’s Thyroiditis, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region, ... Read More
-
Remicade Biosimilar Global Market Report 2023 Including: 1) By Type: 100mg/10ml; 500mg/50ml 2) By Disease Indication: Ulcerative Colitis; Rheumatoid Arthritis; Ankylosing Spondylitis; Crohn’s Disease; Psoriatic Arthritis; Plaque Psoriasis 3) By Application: Blood Disorders; Oncology Diseases Covering: AbbVie Inc.; Novartis AG; Amgen Inc; Viatris Inc.; Teva Pharmaceutical Industries Ltd.
... Novartis AG; Amgen Inc; Viatris Inc.; Teva Pharmaceutical Industries Ltd. Remicade Biosimilar Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess ... Read More
-
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Global Forecast to 2028
... size is projected to reach USD 40.4 billion by 2028 from USD 29.0 billion in 2023, at a CAGR of 6.9% during the forecast period. Expanding the number of plasma collection centers allows market players ... Read More
-
Rheumatoid Arthritis Drugs Market, Size, Share, Global Forecast 2023-2030, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... Research. Rheumatoid Arthritis (RA) is an autoimmune condition characterized by inflammation and joint pain. It occurs when the immune system malfunctions and targets the synovium, the lining of the joints. Generally, RA affects symmetrical joints ... Read More
Research Assistance
